Clinical Trials Logo

Adherence, Medication clinical trials

View clinical trials related to Adherence, Medication.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05634265 Completed - Depression Clinical Trials

Social Media for ART Adherence and Retention in Adolescents and Young Adults: the Vijana-SMART Study

Start date: January 31, 2019
Phase: N/A
Study type: Interventional

The goal of this study is to investigate whether a virtual peer support group improves ART knowledge, adherence, and mental health in youth living with HIV in Kenya.

NCT ID: NCT05366621 Completed - Osteoporosis Clinical Trials

Post-fracture Medication and Mortality

Start date: November 1, 2020
Phase:
Study type: Observational

Osteoporotic fracture is a common public-health problem in the whole world. Although postfracture usage of anti-osteoporosis medications, may reduce mortality, recent results have been inconsistent. The investigators aim to examine associations between osteoporosis medication and mortality in older adults and any type of fracture patients. The investigators also aim to discuss the pleiotropic effects of different types of anti-osteoporosis medications.

NCT ID: NCT05312242 Completed - Clinical trials for Adherence, Medication

Introduction of MMS to Antenatal Care in Bamako, Mali

MAMAN
Start date: February 10, 2022
Phase: N/A
Study type: Interventional

The aim of this implementation research is to compare how different implementation strategies influence the acceptability and adherence to antenatal supplement use in pregnancy.

NCT ID: NCT05291000 Completed - Hypertension Clinical Trials

The Role of Training and Reminder Wristwatche in Hypertension

RoT-ReWiH
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This study is a randomized controlled study. The study was completed to with randomized selected 30 training and reminder by watch (experiment), 30 education (experiment) and 30 control group total of 90 hypertensive patients. Patients in the experimental group received training on hypertension and treatment adherence. In addition, the participants in the training and reminder by watch group wore a medication reminder wristwatch. Statistically significant differences were found in the post-test between scale scores of the experimental and control groups (p<.05). It was observed that the initial blood pressure measurements were high in the patients in all three groups, while the highest decrease was found in the training and reminder by wristwatch group at the final measurement (p<.05). Hypertension education program and using a medication reminder wristwatch were found to be effective in increasing treatment adherence.

NCT ID: NCT05233644 Completed - Heart Failure Clinical Trials

Medication Adherence in Heart Failure After Hospitalisation

Start date: October 28, 2021
Phase:
Study type: Observational

To explore medication adherence in patients who were hospitalised due to heart failure.

NCT ID: NCT05168449 Completed - Clinical trials for Chronic Kidney Diseases

The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients

Start date: September 17, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to assess the impact of pharmacist led mobile application on adherence and efficacy of medication in chronic kidney disease patients

NCT ID: NCT05094986 Completed - Clinical trials for Adherence, Medication

Feasibility and Acceptability of a Complex Intervention to Improve Initial Medication Adherence

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

This pilot study aims to test the feasibility of the following effectiveness and cost-effectiveness evaluation using Real-World Data.

NCT ID: NCT04870671 Completed - HIV/AIDS Clinical Trials

Project ADHERE: Clinical Proof-of-Concept of a Tenofovir (TFV) Aptamer-Based Biosensor

Start date: March 25, 2021
Phase: Early Phase 1
Study type: Interventional

Truvada®, an oral pill comprised of two anti-retroviral compounds, emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), is currently the only drug combination approved for pre-exposure prophylaxis (PrEP) in women exposed to high HIV risk through vaginal acquisition. Adherence to the one pill per day regimen is crucial for its effectiveness in reducing the risk of acquiring HIV. Currently, there is no available point of care diagnostic test to quickly measure blood levels of tenofovir in the clinic. This study will determine whether a tenofovir (TFV) aptamer-based biosensor (aptasensor) can detect TFV in biological fluids from women randomized to different dosing regimens representing high and low adherence.

NCT ID: NCT04868383 Completed - HIV Prevention Clinical Trials

Using Smart Phone Technology to Support PrEP Uptake and Adherence

prep'd
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This is a single arm pilot study of a new smartphone app to support adherence to PrEP medication for HIV prevention in public clinics in Virginia.

NCT ID: NCT04861896 Completed - Quality of Life Clinical Trials

A Research Study for Latina Women With Breast Cancer

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility and preliminary efficacy of a psychosocial eHealth intervention designed to improve hormone therapy adherence among Hispanic/Latinx women with breast cancer. Our proposed secondary outcomes are health-related quality of life and self-efficacy in managing hormone therapy side effects. The intervention components include breast cancer knowledge, hormone/endocrine therapy knowledge, stress awareness and management, social support, and enhanced communication and intimacy skills. The intervention will be delivered via a Smartphone application over a 12-week period. All participants will receive the intervention application (described below). Aside from using the Smartphone application for the recommended 12 weeks, participation in this study includes three assessments: baseline (at the beginning of the research study), 6-week follow-up, and 12-week follow-up.